Non-prescription drugs suffer from inflation

  • Post category:Economy News
  • Reading time:4 mins read

From +5.9 to +8.2%. The prices of over-the-counter products in pharmacies are skyrocketing. And it’s not over. These increases will continue between September and January.

Article reserved for subscribers

Journalist in the Economy department

Reading time: 6 mins

QWhich sector has not escaped the rise in the cost of living? In any case not that of the drug, despite its essential nature. Admittedly, molecules under prescription and reimbursed have not kept pace with inflation (9.62% in July) because their price is set by the Inami and the National Institute for Health and Disability Insurance has preserved the state (and patients) of an outbreak of tablets. But for other over-the-counter drugs, and although they are subject to maximum prices left to the discretion of the federal public authorities, a marked increase in the price is already perceptible, according to data from Redpharma. Owned by Iqvia, the American health data giant, the Belgian company specializing in particular in pharmaceutical market studies reports to the Evening “price increases for non-regulated products higher on average than the previous year over the period from January to July. »

This article is for subscribers only

With this offer, enjoy:
  • Unlimited access to all the articles, files and reports of the editorial staff
  • The newspaper in digital version
  • Reading comfort with limited advertising